Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 8, 2023
Hypusination-induced DHPS/eIF5A pathway as a new therapeutic strategy for human diseases: A mechanistic review and structural classification of DHPS inhibitorsJing-Si Guo, Kai-Li Liu, Yu-Xi Qin, et al.
Epilepsia|May 28, 2014
Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsyXiao-Jing He, Ling-Yan Jian, Xiao-Lin He, et al.
Pharmacological Reports : PR|January 9, 2014
Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern ChinaXiao-Jing He, Ling-Yan Jian, Xiao-Lin He, et al.
European Journal of Medicinal Chemistry|April 22, 2022
Synthesis and evaluation of novel HER-2 inhibitors to exert anti-breast cancer ability through epithelial-mesenchymal transition (EMT) pathwayXin-Yang Li, Xin-Hua Qian, Ju Zhu, et al.
Bioorganic Chemistry|December 16, 2021
Discovery of N-(1,3,4-thiadiazol-2-yl)benzamide derivatives containing a 6,7-methoxyquinoline structure as novel EGFR/HER-2 dual-target inhibitors against cancer growth and angiogenesisXin-Yang Li, De-Pu Wang, Shuai Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 2, 2024
DHPS-Mediated Hypusination Regulates METTL3 Self-m6A-Methylation Modification to Promote Melanoma Proliferation and the Development of Novel InhibitorsJing-Si Guo, Jian Ma, Xi-He Zhao, et al.
Pageof 2